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Purpose: The objective of this study was to retrospectively evaluate the analgesic effects of 
continuous radiofrequency lesioning of the suprascapular nerve (SSN) for chronic shoulder 
pain. The authors sought to obtain insight into the time-sensitive analgesic success and com-
plications of this therapy.
Patients and methods: This study was a retrospective case series involving patients with 
unremitting shoulder pain that had lasted for at least 12 months. Patients were selected if they 
showed a reduction of at least 50% in pain intensity during the anesthetic phase after SSN block, 
no additional motor weakness of the shoulder, and pain relief lasting for less than 2 months after 
separate treatments of the SSN with depot corticosteroids and pulsed radiofrequency. Nine patients 
were referred to the Arnold Pain Management Center. Of these nine patients, six patients who had 
significant chronic shoulder pain unresponsive to oral medications and intra-articular injections 
and who were not considered surgical candidates were selected. These patients were treated with 
a single radiofrequency lesion of the SSN at 80°C for 60 seconds. The primary outcome was a 
reduction in pain intensity by 50%, as determined by the numeric rating scale, and duration of this 
effect. The secondary outcome was improvement in either the passive or the active range of motion 
(ROM). Patients were also monitored for adverse effects such as weakness or increased pain.
Results: The pooled mean numeric rating scale score before the procedure was 7.2 ± 1.2; 
this fell to 3.0 ± 0.9 at 5–7 weeks post procedure. The duration of pain relief ranged from 3 to 
18 months, and all patients underwent at least one additional treatment. The change in baseline 
ROM improved from an average of 60° ± 28° (flexion) and 58° ± 28° (abduction) to 99° ± 46° 
(flexion) and 107° ± 39° (abduction). No adverse side effects were observed.
Conclusion: Continuous radiofrequency lesioning of the SSN seems to be an effective treat-
ment for chronic shoulder pain. There can be improved ROM of the shoulder following this 
treatment. More formal, controlled studies are required to confirm these observations.
Keywords: pulsed radiofrequency, suprascapular nerve block, pain relief, range of motion
Introduction
Chronic shoulder pain is a frequent clinical condition that often reduces a patient’s 
function and rehabilitation potential. The most common etiologies of chronic 
shoulder disorders include rotator cuff syndrome, glenohumeral joint osteoarthritis, 
adhesive capsulitis, posttraumatic pain, and persistent pain following surgery.1 Not 
uncommonly, conventional pharmacotherapy may either have too many side effects 
or be ineffective. Physical therapy is often abandoned because of persistent intoler-
able pain, and a progressive decline in range of motion (ROM) and function ensues. 
Furthermore, a substantial number of patients may not be appropriate surgical 
candidates or they may have significant medical comorbidities.
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Suprascapular nerve block (SSNB) has a long history of 
reducing pain and improving ROM in patients with shoulder 
pain.2 The suprascapular nerve (SSN) innervates nearly 70% 
of the shoulder joint, and therefore its blockade is a com-
monly accepted mode of pain therapy in acute and chronic 
settings.3 Pain relief from a SSNB may last for hours only 
but relief can be more prolonged if depot steroids are added.4 
Nonetheless, the number of patients with time-sensitive anal-
gesia too brief to be clinically practical is significant.
More recently, pulsed radiofrequency (PRF) treat-
ment of the SSN has emerged as an alternative mode for 
prolonged relief of chronic shoulder pain.5–7 PRF is a very 
attractive mode of treatment because of its minimally 
destructive nature.8 Despite its exact mechanism of action 
being unclear, PRF has particular advantages when treating 
mixed sensory and motor peripheral nerves. In comparison 
with neurolytic techniques, PRF treatment is felt to function 
at a more neuromodulatory level, and therefore the risks of 
deafferentation, neuritis, and neuroma formation are felt to 
be minimal.5 Repeat treatments via PRF are easily achieved 
because the target nerve is left intact. Finally, application of 
PRF to the SSN does not risk paralysis of the supraspinatus 
and infraspinatus muscles.
However, the authors have encountered a series of patients 
with intractable shoulder pain who responded to both SSNB and 
PRF of the SSN for a short-lived duration. The authors describe 
the selection of patients based on preexisting motor function and 
SSNB with local anesthetic. The patients underwent continuous 
(or conventional) radiofrequency (CRF) lesioning of the SSN 
in order to derive more sustained benefit.
Methods
Over two years, nine patients were referred to the Arnold Pain 
Management Center (Brookline, MA) with severe chronic 
shoulder pain. In addition to a careful history and physical 
examination, a diagnosis of anatomic pathology was made in 
each patient with magnetic resonance imaging. The patients 
were treated conservatively with extensive physical therapy, 
intra-  articular steroid injections, trigger point injections, non-
steroidal anti-inflammatory drugs, and opioids. None of the 
patients were considered suitable candidates for surgery.
In addition, all patients underwent a diagnostic SSNB 
after initial evaluation. The SSNB was performed with the 
use of fluoroscopy, with the patient in either the prone or the 
sitting position. A 22-gauge spinal needle was advanced to 
the suprascapular notch and 5 mL of 2% lidocaine with depot 
methylprednisolone acetate (20 mg). In order to be consid-
ered for PRF treatment (42°C for 120 seconds at each time) 
the following criteria had to be met: (1) a decline of at least 
50% in the numeric rating scale (NRS) score on anesthetic 
phase and (2) pain relief lasting for less than 2 months. Six 
of the nine patients met these criteria.
To be considered for CRF, all conditions for PRF had 
to be fulfilled as well as the failure of PRF to provide at 
least 2 months of pain relief. In addition, for patients who 
had any active mobility of the shoulder, motor testing was 
performed after a repeat SSNB with 2 cm3 of 5% lidocaine. 
Motor testing via standard physical examination, graded 
from 0 (no evidence of contractility) to 5 (complete range 
of motion against gravity, with full resistance), focused on 
those muscles innervated by the SSN that included abduction 
(supraspinatus) and external rotation (infraspinatus). CRF 
treatment was not offered if the patient or the examining 
physician noticed any shoulder weakness.
The fluoroscopic approach used in nerve blockade, PRF 
treatment, and CRF treatment has been well described in 
the past and was employed in this case series.5 In summary, 
the patients were placed on the fluoroscopy table in the prone 
position with his or her arm tucked to the side. The sitting 
position was used for the hemiplegic patients who could 
not tolerate the prone position (Figure 1). In either position, 
under C-arm fluoroscopy, the electrode was guided to the 
apex of the suprascapular notch. The suprascapular notch 
was identified in an immediate proximal and medial posi-
tion to the coracoid process; this is because of the “rounded 
shoulder” posture of patients with chronic shoulder pain. 
To delineate between the two structures it is necessary for 
the C-arm to be at an oblique angle of 15°–25°, since the 
coracoid blocks the view of the suprascapular notch, particu-
larly in the sitting position (Figure 2). Also, a cephalocaudal 
angle (15°–25°) must be added to visualize the spine of the 
scapula, the prone position was again more advantageous 
for this (Figure 3).
The proximity of a 22-gauge SMK C5 electrode (51 mm, 
4 mm active tip; Radionics, Burlington, MA) to the SSN was 
determined by sensory stimulation at 50 Hz. Reproducible 
paresthesias covering the shoulder joint (mostly the posterior 
aspect) were elicited at a voltage range of 0.1–0.5 V . Motor 
stimulation at 2 Hz produced objective contractions of the 
supraspinatus and infraspinatus muscle groups at a range of 
0.1–0.85 V . A single radiofrequency thermocoagulation lesion 
was performed at 80°C for 60 seconds using a radiofrequency 
generator (RFG-3B; Radionics, Burlington, MA).
The primary clinical outcome measure was a reduction 
in pain intensity as determined by the NRS (an   eleven-point 
scale, from 0 to 10). A 50% or greater reduction in the NRS 
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score following the procedure was defined as “effective.”9 
Serial treatment were offered when this criterion was met. 
Secondary clinical outcome measures were improvements 
in the ROM of the glenohumeral joint, which included pas-
sive ROM for those patients with significant loss of shoulder 
mobility and active ROM for those patients with preserved 
motor function. Flexion and abduction were most limited 
in this selected group of  patients and were consistently 
evaluated and recorded. Motor testing was performed using 
a graded scale from 0 to 5 where 5 represents full motor 
strength and 0 is no movement. The time-sensitive success of 
CRF lesioning was monitored by routine clinical follow-up 
at 5–7 weeks post procedure. Lastly, adverse events such 
as loss of function and perceived or objective weakness 
of the rotator cuff muscles, as determined by the physical 
examination, were carefully assessed. Worsening pain that 
could signify potential neuritis was screened for in follow-up 
visits. All data including NRS scores, ROM, number of 
repeat CRF procedures, and details of any adverse events 
were collected retrospectively from the electronic and 
paper charts. The change in the visual analogue scale score 
associated with pain pre-CRF to post-CRF treatment was 
then subjected to statistical evaluation using a two-tailed 
Student’s t-test.
Results
The mean age of the patients in this study was 54 years (Table 1). 
These patients had been suffering from chronic shoulder pain for 
an average of  2.3 years before the study. The duration of pain 
relief from SSNB and PRF treatment ranged from 1 to 5 days 
and 1 to 4 weeks, respectively. In this retrospective case series, 
the pooled mean NRS score was 7.2 ± 1.2, declining to 3.0 ± 0.9 
(P , 0.01) at 5–7 weeks post procedure. Table 2 summarizes the 
time-sensitive pain relief and the number of repeat procedures 
with similar impact on pain intensity and duration.
The effects of pain reduction on shoulder ROM increased 
modestly from a baseline average of 60° ± 28° (flexion) and 
58° ± 28° (abduction) to 99° ± 46° (flexion) and 107° ± 39° 
(abduction). The first three patients shown in Table 1 (all three 
had adhesive capsulitis) had significant atrophy of the rota-
tor cuff muscles, as well as such limited ROM that they did 
not notice loss of motor function with either local anesthetic 
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Figure 1 When visualizing the suprascapular notch under fluoroscopy, certain patients may find the only tolerable position to be the sitting position. 
Copyright © 2009, ASIPP Publishing. Adapted with permission from Sial KA, Simopoulos TT, Malik AB. Suprascpular nerve block. In: Interventional Techniques in Chronic   
Non-spinal Pain. Peducah, KT: ASIPP Publishing; 2009.
Note: The Positioning of the C-arm at an oblique angle of 15°–25° and a cephalocaudal angle of approximately 15°–25°.Journal of Pain Research 2012:5
  blockade or thermocoagulation of the SSN. The last three 
patients shown in Table 1 also had significant atrophy of the 
rotator cuff muscles, with one of the patients having total 
disruption of the supraspinatus and infraspinatus tendons, and 
they did not experience weakness on local anesthetic blockade, 
even with 5% lidocaine. On follow-up evaluation, the ROM 
was improved, and neither the patients nor the examining physi-
cian could notice increased weakness, even after repeat CRF 
treatments. There were no persistent dysesthesias or worsening 
pain, even on recurrent CRF lesioning of the SSN.
Discussion
This report retrospectively describes a small group of 
patients who have documented consistent pain relief through 
thermocoagulation of the SSN. These carefully selected 
patients had experienced prior local anesthetic blockade of 
the SSN without clinically apparent loss of function, and 
the physical examination of these patients was suggestive of 
atrophy and loss of use of the infraspinatus and supraspinatus 
muscles. PRF treatment was the immediate second choice of 
therapy for prolonged relief once blockade of the SSN with 
local anesthetic and depot methylprednisolone acetate proved 
clinically effective, but was short-lived. This is the first case 
series to evaluate the potential effectiveness of CRF of the 
SSN when pain relief from prior PRF treatment was also too 
short-lived to be clinically meaningful. The authors acknowl-
edge the bias when reporting retrospectively on a small case 
series with heterogeneous causes of shoulder pain.
Historically, chronic shoulder pain has been a challeng-
ing problem for the patient and the physician because of the 
limited options available for prolonged pain relief and chance 
for improved function. Chronic shoulder pain is exceeded 
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Figure 2 Radiofrequency cannula placed in the wide, blunted V-shaped notch with the patient in the sitting position.Journal of Pain Research 2012:5
in clinical prevalence only by back pain, neck pain, and 
  headache.10 Traditionally, chronic shoulder pain commonly 
due to glenohumeral arthritis, adhesive capsulitis, or rotator 
cuff tears has not been amenable to interventional techniques. 
Once a patient exhausts the conventional options of physi-
cal therapy, anti-inflammatory medications, intra-articular 
  injections, and corrective/reconstructive surgery, persistent 
pain is not uncommonly managed with long-term opioids. 
Thus, few patients are referred to pain management clinics.
The SSN has become a target of intervention because of 
its extensive sensory nerve supply to the shoulder structures, 
including the posterior glenohumeral joint capsule, acromio-
clavicular joint, subacromial bursa, and coracoclavicular 
  ligament.11 This mixed motor-sensory nerve arises from the 
upper trunk on the brachial plexus (containing mainly C5 and 
C6 fibers) and then courses inferiorly, laterally, and posteriorly 
to enter the supraspinatus fossa via the suprascapular notch. 
After supplying the supraspinatus muscle, the nerve curves 
around the spinoglenoid notch to innervate the infraspinatus 
muscle. The suprascapular notch is an important structure 
to identify on fluoroscopy, and clinicians should be aware 
of the two most common morphologies of the notch that 
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Figure 3 Radiofrequency cannula placed in the classic U-shaped notch with the patient in the prone position.Journal of Pain Research 2012:5
have been described.12 The wide, blunted V-shaped notch 
is present in 39% of individuals (Figure 2), while the 
more   classic, symmetrical U-shaped notch is seen in 48% 
 ( Figure 3). SSNB in the management of degenerative shoul-
der joint disease is felt to be a safe and effective treatment 
according to a previous randomized, double-blind, placebo-
controlled trial.13 The proportion of patients experiencing 
pain relief at months rather than weeks post SSNB was as 
high as 55% of all patients initially treated. However, other 
authors have reported a shorter duration of pain relief post 
SSNB, where only 29% of patients reported noticeable pain 
relief at 3 weeks.14
Prior to the application of PRF to the SSN, percutaneous 
neurolysis with either cryoablation or phenol of the SSN has 
been described previously.15,16 Using 6% phenol, Lewis16 doc-
umented a reduction in pain intensity and an improved ROM 
in flexion and abduction. In the present study the authors 
also observed improvements in active ROM without loss 
of   function. To reconcile this   observation, it is important to 
  realize that abduction and external rotation are not exclusively 
dependent on the supraspinatus and infraspinatus muscles, 
respectively.17 The middle and anterior deltoid muscle and 
the serratus anterior muscle are involved in abduction. The 
teres minor muscle and the posterior portion of the deltoid 
muscle are responsible, in addition to the infraspinatus, for 
external rotation. Therefore, lesioning of motor nerve fibers 
to half of the rotator muscles does not consistently result in 
functional deterioration; rather, it results in improvement, 
because complimentary muscles are employed in the setting 
of pain reduction.
CRF treatment was chosen over chemical neurolysis or 
cryoanalgesia for several reasons. The spread of chemical 
neurolytic agents cannot be controlled precisely because   
they negatively impact adjacent   structures via protein dena-
turation. CRF treatment causes small focal lesions and can be 
repeated with reproducible results over time, as the authors 
observed in the case series. CRF treatment is regarded as a 
safe ablative therapy with a low incidence of complications.18 
Table 2 Time-sensitive improvement of pain intensity and range of motion (ROM) using suprascapular nerve radiofrequency lesioning
Patient Pre-treatment 
NRS score
Post-treatment 
NRS score  
(at 5–7 weeks)
Pre-treatment 
ROM 
[F/A]
Post-treatment 
ROM 
[F/A]
Duration of relief 
(months)
Repeat procedures   
(n)
1 7 2 60°/60° (P) 90°/90° (P) 18 1
2 9 4 60°/50° (P) 80°/80° (P) 4 2
3 6 2 20°/20° (P) 45°/90° (P) 4 3
4 6 3 90°/90° (A) 120°/120° (A) 3 1
5 7 3 90°/90° (A) 180°/180° (A) 6 2
6 8 4 40°/40° (A) 80°/80° (A) 6 2
Abbreviations: A, active; F/A, flexion and abduction; NRS, numeric rating scale; P, passive.
Table  1  Demographics of  six  patients  with  chronic  shoulder  pain  who  underwent  continuous  radiofrequency  lesioning  of  the 
suprascapular nerve
Patient Age (years) Sex Duration of pain  
(years)
Diagnosis Etiology of condition Surgery
1 67 M 3 Adhesive capsulitis Right-sided stroke, trauma,  
immobilization
MUA, arthroscopic  
LOA
2 54 F 3 Adhesive capsulitis Right-sided stroke,  
immobilization
None
3 37 F 2 Adhesive capsulitis Trauma, CRPS 1 Arthroscopic LOA  
and capsular release
4 44 M 2 Glenohumeral 
osteoarthritis, prior  
bankart lesion
Left hemiparesis following 
meningitis
Bankart repair
5 78 M 1 Rotator cuff tear Unrepairable full-thickness  
tears of supraspinatus and  
infraspinatus tendons
Attempted repair
6 44 F 3 Glenohumeral  
osteoarthritis
Proximal humeral head  
resection, chondrosarcoma
Bankart repair,  
intralesional curettage
Abbreviations: CRPS 1, complex regional pain syndrome type 1; F, female; LOA, lysis of adhesions; M, male; MUA, manipulation under anesthesia.
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  Radiofrequency was chosen over cryoablation because of 
ease of use, probe size, and the potential for lesioning of 
sensory fibers over motor fibers. While the preclinical studies 
support the indiscriminate radiofrequency lesioning of both 
motor and sensory fibers, lesioning of the trigeminal nerve for 
trigeminal neuralgia suggests otherwise.19 Specifically, Tew 
and Taha19 reported on 1200 cases of trigeminal neuralgia 
with a masticatory muscle weakness rate of 23%.
Conclusion
In summary, this report suggests that percutaneous CRF 
lesioning of the SSN may be effective for refractory shoulder 
pain. Conventional thermocoagulation methods may extend 
the duration of pain relief in patients for whom less destruc-
tive methods such as depot steroids or PRF treatment prove 
inadequate. Careful evaluation and selection of patients for 
this procedure is necessary in order to obtain optimal clinical 
outcomes.
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